MIOX and hepatocellular carcinoma: For example, lncRNA-NEAT1 enhances MIOX expression by competitively binding to miR-362-3p, thereby increasing ferroptosis and offering a potential strategy for improving chemotherapy sensitivity in hepatocellular carcinoma (HCC) patients (107).